Research Program Manager H-Center for TB Publications Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial. M_Neurology Kaur P, Chaisson LH, Kiragu ZW, Buddadhumaruk P, Austin AF, Gao Y, Wirtz VJ, Arbeit RD, Fetalvero KB, Nguyen HB, Nguyen NV, Ha H, Eisenach K, Walter ND, Mitnick CD, Gler MTS, Phan H, Nahid P, Phillips PPJ, Horsburgh CR, Velásquez GE Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis. Prajna NV, Radhakrishnan N, Lalitha P, Rajaraman R, Narayana S, Austin AF, Liu Z, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J Predictors of Vision-Related Quality of Life After Endothelial Keratoplasty in the Descemet Endothelial Thickness Comparison Trials. Pickel J, Chamberlain WD, Lin CC, Austin A, Clover J, Lietman TM, Rose-Nussbaumer J Descemet Endothelial Thickness Comparison Trial: Two-Year Results from a Randomized Trial Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty with Descemet Membrane Endothelial Keratoplasty. Rose-Nussbaumer J, Lin CC, Austin A, Liu Z, Clover J, McLeod SD, Porco TC, Lietman TM, Dresner SM, Benetz BA, Lass JH, Chamberlain WD Effect of Unilateral Endothelial Keratoplasty on Vision-Related Quality-of-Life Outcomes in the Descemet Endothelial Thickness Comparison Trial (DETECT): A Secondary Analysis of a Randomized Clinical Trial. Ang MJ, Chamberlain W, Lin CC, Pickel J, Austin A, Rose-Nussbaumer J Update on the Management of Infectious Keratitis. Austin A, Lietman T, Rose-Nussbaumer J Empirical treatment of bacterial keratitis: an international survey of corneal specialists. Austin A, Schallhorn J, Geske M, Mannis M, Lietman T, Rose-Nussbaumer J Person Type Override (full) staff
Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial. M_Neurology Kaur P, Chaisson LH, Kiragu ZW, Buddadhumaruk P, Austin AF, Gao Y, Wirtz VJ, Arbeit RD, Fetalvero KB, Nguyen HB, Nguyen NV, Ha H, Eisenach K, Walter ND, Mitnick CD, Gler MTS, Phan H, Nahid P, Phillips PPJ, Horsburgh CR, Velásquez GE
Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis. Prajna NV, Radhakrishnan N, Lalitha P, Rajaraman R, Narayana S, Austin AF, Liu Z, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J
Predictors of Vision-Related Quality of Life After Endothelial Keratoplasty in the Descemet Endothelial Thickness Comparison Trials. Pickel J, Chamberlain WD, Lin CC, Austin A, Clover J, Lietman TM, Rose-Nussbaumer J
Descemet Endothelial Thickness Comparison Trial: Two-Year Results from a Randomized Trial Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty with Descemet Membrane Endothelial Keratoplasty. Rose-Nussbaumer J, Lin CC, Austin A, Liu Z, Clover J, McLeod SD, Porco TC, Lietman TM, Dresner SM, Benetz BA, Lass JH, Chamberlain WD
Effect of Unilateral Endothelial Keratoplasty on Vision-Related Quality-of-Life Outcomes in the Descemet Endothelial Thickness Comparison Trial (DETECT): A Secondary Analysis of a Randomized Clinical Trial. Ang MJ, Chamberlain W, Lin CC, Pickel J, Austin A, Rose-Nussbaumer J
Empirical treatment of bacterial keratitis: an international survey of corneal specialists. Austin A, Schallhorn J, Geske M, Mannis M, Lietman T, Rose-Nussbaumer J
